Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

15:17 ETInovativní léčba Alzheimerovy choroby z Číny uzavře 3. fázi klinických studií

Společnost Green Valley Pharmaceutical Co., Ltd. (Green Valley) dnes oznámila, že její 3. fáze studie tobolek s přísadou oligomannurarátu sodného...


09:30 ETHighlights from Lilly's Alzheimer's Disease Pipeline at the Alzheimer's Association International Conference® 2018 (AAIC® 2018)

Eli Lilly and Company (NYSE: LLY) today announced that new results from a number of studies across the company's Alzheimer's disease pipeline will be ...


09:00 ETCSL Behring Hosts Symposium on Managing CIDP with Immunoglobulin, Supports 14 Scientific Posters and Two Oral Presentations at the 2018 Peripheral Nerve Society Annual Meeting

Global biotherapeutics leader CSL Behring today announced that it will support the presentation of 14 scientific posters at the 2018 annual meeting...


08:00 ETNew Study demonstrates significant role food banks play in improving food security

Feeding America, the nation's largest hunger-relief organization with 200 member food banks, concluded a two-year, randomized controlled research...


07:47 ETKlinische Studie der Phase 3 für innovative Alzheimer-Behandlung aus China abgeschlossen

Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) gab heute bekannt, dass seine Phase-3-Studie zu Kapseln mit dem Arzneimittel „Sodium...


Jul 19, 2018, 23:46 ETENDOSCOPY publie l'essai MORA de phase III portant sur PLENVU® (NER1006), la seule préparation des intestins d'un litre à base de PEG[i]

Norgine B.V. a annoncé aujourd'hui que les résultats de l'étude MORA de phase III portant sur PLENVU® ont été publiés dans ENDOSCOPY, une revue...


Jul 19, 2018, 17:07 ETENDOSCOPY veröffentlicht Phase-III-Studie MORA für PLENVU® (NER1006), die einzige 1-Liter PEG-basierte Darmreinigung[i]

Norgine B.V. hat die Veröffentlichung der Ergebnisse der Phase-III-Studie MORA zu PLENVU® in ENDOSCOPY bekanntgegeben, eine monatlich erscheinende,...


Jul 19, 2018, 16:51 ETJournal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos® (daunorubicin and cytarabine) Liposome for Injection

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that data from the pivotal Phase 3 study of Vyxeos® (daunorubicin and cytarabine) liposome...


Jul 19, 2018, 16:45 ETJournal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos® (daunorubicin and cytarabine) Liposome for Injection

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that data from the pivotal Phase 3 study of Vyxeos® (daunorubicin and cytarabine) liposome...


Jul 19, 2018, 14:47 ETUn traitement chinois novateur de la maladie d'Alzheimer conclut les essais cliniques de phase 3

Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) a annoncé aujourd'hui que son étude de phase 3 d'administration de capsules...


Jul 19, 2018, 14:15 ETAlopexx Vaccine Reports Successful Maternal Immunization Protecting Foals from an Intracellular Equine Pathogen Similar to Tuberculosis

Alopexx Vaccine LLC today announced the publication of positive data for a veterinary vaccine demonstrating 91% protective efficacy in horse foals...


Jul 19, 2018, 12:25 ETENDOSCOPY publica en el ensayo de fase III MORA para PLENVU® (NER1006)

- ENDOSCOPY publica en el ensayo de fase III MORA para PLENVU® (NER1006), la única preparación intestinal de 1 litro basada en PEG[i] Norgine B.V. ha ...


Jul 19, 2018, 11:08 ETInnowacyjny lek na chorobę Alzheimera z Chin w końcu badań klinicznych w fazie 3

Firma Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) ogłosiła dziś, że badania w fazie trzeciej dotyczące kapsułek substancji Sodium...


Jul 19, 2018, 10:53 ETAlligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


Jul 19, 2018, 10:31 ETTratamento inovador da China para Alzheimer conclui a fase 3 dos testes clínicos

A Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) anunciou hoje que a fase 3 de seu estudo das cápsulas oligomannurarato de sódio...


Jul 19, 2018, 10:20 ETResearchers Are One Step Closer to Developing Eye Drops to Treat Age-related Macular Degeneration (AMD)

Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise treatment for age-related...


Jul 19, 2018, 10:16 ETInovatívna liečba Alzheimerovej choroby z Číny je na konci klinického skúšania fázy 3

Spoločnosť Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) dnes oznámila, že klinické skúšanie kapsúl oligomannurarátu sodného (GV-971) ...


Jul 19, 2018, 09:46 ETInnovador tratamiento chino contra la enfermedad de Alzheimer concluye los ensayos clínicos de fase 3

Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) anunció hoy que su estudio de fase 3 con cápsulas de oligomannurarato de sodio (GV-971) ...


Jul 19, 2018, 09:08 ETWorking to Improve Hemophilia A Testing: Precision BioLogic presents new data at the 64th Annual SSC meeting

HALIFAX, July 19, 2018 /PRNewswire/ - Precision BioLogic today unveiled data from a study using a new kit for a Modified Nijmegen-Bethesda Assay...


Jul 19, 2018, 08:30 ETAevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it received positive feedback from the United States Food and Drug...


Jul 19, 2018, 08:30 ETENDOSCOPY Publishes the MORA Phase III Trial for PLENVU® (NER1006), the Only 1 Litre Peg Based Bowel Preparation[i]

Norgine B.V. today announced that results from the PLENVU® Phase III MORA trial were published in ENDOSCOPY, a monthly peer-reviewed medical journal...


Jul 19, 2018, 08:00 ETBoehringer Ingelheim and Lilly announce Tradjenta's CARMELINA® cardiovascular outcome trial meets primary endpoint

CARMELINA® (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its...


Jul 19, 2018, 08:00 ETEnteris BioPharma's "Feasibility-to-Licensing" Partner, Cara Therapeutics, Doses First Patient in Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies,...


Jul 19, 2018, 08:00 ETAllergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company and Molecular Partners (SIX: MOLN), a clinical-stage biopharmaceutical company...


Jul 19, 2018, 08:00 ETGT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination With a Multi-Billion Dollar Oncology Drug

GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP.PA) announced today a Material Transfer Agreement (MTA) between a Major Pharmaceutical Company and ...